Non-invasive fecal metabonomic detection of colorectal cancer

References

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 Lyon, France: International Agency for Research on Cancer, 2010.
   Google Scholar
• American Cancer Society Cancer Facts and Figures. American Cancer Society, 2012.
   Google Scholar
• Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE. Noninvasive testing for colorectal cancer: a review. Am J Gastroenterol 2005; 100:1393 - 403; http://dx.doi.org/10.1111/j.1572-0241.2005.41427.x; PMID: 15929776
   PubMed Web of Science ®Google Scholar
• Ransohoff DF, Sandler RS. Clinical practice. Screening for colorectal cancer. N Engl J Med 2002; 346:40 - 4; http://dx.doi.org/10.1056/NEJMcp010886; PMID: 11778002
   PubMed Web of Science ®Google Scholar
• Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005; 128:192 - 206; http://dx.doi.org/10.1053/j.gastro.2004.10.041; PMID: 15633136
   PubMed Web of Science ®Google Scholar
• Takai T, Kanaoka S, Yoshida K, Hamaya Y, Ikuma M, Miura N, Sugimura H, Kajimura M, Hishida A. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 2009; 18:1888 - 93; http://dx.doi.org/10.1158/1055-9965.EPI-08-0937; PMID: 19505922
   PubMed Web of Science ®Google Scholar
• Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell 2008; 13:472 - 82; http://dx.doi.org/10.1016/j.ccr.2008.05.005; PMID: 18538731
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646 - 74; http://dx.doi.org/10.1016/j.cell.2011.02.013; PMID: 21376230
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029 - 33; http://dx.doi.org/10.1126/science.1160809; PMID: 19460998
   PubMed Web of Science ®Google Scholar
• Benjamin DI, Cravatt BF, Nomura DK. Global profiling strategies for mapping dysregulated metabolic pathways in cancer. Cell Metab 2012; 16:565 - 77; http://dx.doi.org/10.1016/j.cmet.2012.09.013; PMID: 23063552
   PubMed Web of Science ®Google Scholar
• Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res 2009; 8:352 - 61; http://dx.doi.org/10.1021/pr8006232; PMID: 19063642
   PubMed Web of Science ®Google Scholar
• Mal M, Koh PK, Cheah PY, Chan EC. Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry. Anal Bioanal Chem 2012; 403:483 - 93; http://dx.doi.org/10.1007/s00216-012-5870-5; PMID: 22374317
   PubMed Web of Science ®Google Scholar
• Mal M, Koh PK, Cheah PY, Chan ECY. Development and validation of a gas chromatography/mass spectrometry method for the metabolic profiling of human colon tissue. Rapid Commun Mass Spectrom 2009; 23:487 - 94; http://dx.doi.org/10.1002/rcm.3898; PMID: 19140133
   PubMed Web of Science ®Google Scholar
• Ong ES, Zou L, Li S, Cheah PY, Eu KW, Ong CN. Metabolic profiling in colorectal cancer reveals signature metabolic shifts during tumorigenesis. Mol Cell Proteomics 2010; Forthcoming http://dx.doi.org/10.1074/mcp.M900551-MCP200; PMID: 20147338
   PubMedGoogle Scholar
• Piotto M, Moussallieh FM, Dillmann B, Imperiale A, Neuville A, Brigand C, Bellocq JP, Elbayed K, Namer IJ. Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy. Metabolomics 2009; 5:292 - 301; http://dx.doi.org/10.1007/s11306-008-0151-1
   Web of Science ®Google Scholar
• Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, Niesporek S, Noske A, Buckendahl A, Dietel M, et al. Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover. Mol Cancer 2008; 7:72; http://dx.doi.org/10.1186/1476-4598-7-72; PMID: 18799019
   PubMed Web of Science ®Google Scholar
• Lean CL, Newland RC, Ende DA, Bokey EL, Smith IC, Mountford CE. Assessment of human colorectal biopsies by 1H MRS: correlation with histopathology. Magn Reson Med 1993; 30:525 - 33; http://dx.doi.org/10.1002/mrm.1910300502; PMID: 8259052
   PubMed Web of Science ®Google Scholar
• Balamurugan R, Rajendiran E, George S, Samuel GV, Ramakrishna BS. Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol 2008; 23:1298 - 303; http://dx.doi.org/10.1111/j.1440-1746.2008.05490.x; PMID: 18624900
   PubMed Web of Science ®Google Scholar
• Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012; 6:320 - 9; http://dx.doi.org/10.1038/ismej.2011.109; PMID: 21850056
   PubMed Web of Science ®Google Scholar
• Monleón D, Morales JM, Barrasa A, López JA, Vázquez C, Celda B. Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed 2009; 22:342 - 8; http://dx.doi.org/10.1002/nbm.1345; PMID: 19006102
   PubMed Web of Science ®Google Scholar
• Bezabeh T, Somorjai R, Dolenko B, Bryskina N, Levin B, Bernstein CN, Jeyarajah E, Steinhart AH, Rubin DT, Smith IC. Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts. NMR Biomed 2009; 22:593 - 600; http://dx.doi.org/10.1002/nbm.1372; PMID: 19259992
   PubMed Web of Science ®Google Scholar
• Pasikanti KK, Ho PC, Chan EC. Gas chromatography/mass spectrometry in metabolic profiling of biological fluids. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 871:202 - 11; http://dx.doi.org/10.1016/j.jchromb.2008.04.033; PMID: 18479983
   PubMed Web of Science ®Google Scholar
• Lu J, Zhou J, Bao Y, Chen T, Zhang Y, Zhao A, Qiu Y, Xie G, Wang C, Jia W, et al. Serum metabolic signatures of fulminant type 1 diabetes. J Proteome Res 2012; 11:4705 - 11; http://dx.doi.org/10.1021/pr300523x; PMID: 22894710
   PubMed Web of Science ®Google Scholar
• Li X, Xu Z, Lu X, Yang X, Yin P, Kong H, Yu Y, Xu G. Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus. Anal Chim Acta 2009; 633:257 - 62; http://dx.doi.org/10.1016/j.aca.2008.11.058; PMID: 19166731
   PubMed Web of Science ®Google Scholar
• Ye G, Zhu B, Yao Z, Yin P, Lu X, Kong H, Fan F, Jiao B, Xu G. Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometry. J Proteome Res 2012; 11:4361 - 72; http://dx.doi.org/10.1021/pr300502v; PMID: 22768978
   PubMed Web of Science ®Google Scholar
• Pasikanti KK, Esuvaranathan K, Ho PC, Mahendran R, Kamaraj R, Wu QH, Chiong E, Chan EC. Noninvasive urinary metabonomic diagnosis of human bladder cancer. J Proteome Res 2010; 9:2988 - 95; http://dx.doi.org/10.1021/pr901173v; PMID: 20337499
   PubMed Web of Science ®Google Scholar
• Caldeira M, Perestrelo R, Barros AS, Bilelo MJ, Morête A, Câmara JS, Rocha SM. Allergic asthma exhaled breath metabolome: a challenge for comprehensive two-dimensional gas chromatography. J Chromatogr A 2012; 1254:87 - 97; http://dx.doi.org/10.1016/j.chroma.2012.07.023; PMID: 22835687
   PubMed Web of Science ®Google Scholar
• Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J Proteome Res 2007; 6:469 - 79; http://dx.doi.org/10.1021/pr060594q; PMID: 17269704
   PubMed Web of Science ®Google Scholar
• Wiklund S, Johansson E, Sjöström L, Mellerowicz EJ, Edlund U, Shockcor JP, Gottfries J, Moritz T, Trygg J. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem 2008; 80:115 - 22; http://dx.doi.org/10.1021/ac0713510; PMID: 18027910
   PubMed Web of Science ®Google Scholar
• Calvani R, Miccheli A, Capuani G, Tomassini Miccheli A, Puccetti C, Delfini M, Iaconelli A, Nanni G, Mingrone G. Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. Int J Obes (Lond) 2010; 34:1095 - 8; http://dx.doi.org/10.1038/ijo.2010.44; PMID: 20212498
   PubMed Web of Science ®Google Scholar
• Vallejo M, García A, Tuñón J, García-Martínez D, Angulo S, Martin-Ventura JL, Blanco-Colio LM, Almeida P, Egido J, Barbas C. Plasma fingerprinting with GC-MS in acute coronary syndrome. Anal Bioanal Chem 2009; 394:1517 - 24; http://dx.doi.org/10.1007/s00216-009-2610-6; PMID: 19172251
   PubMed Web of Science ®Google Scholar
• Sharif AW, Williams HR, Lampejo T, Khan SA, Bansi DS, Westaby D, Thillainayagam AV, Thomas HC, Cox IJ, Taylor-Robinson SD. Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy. HPB (Oxford) 2010; 12:396 - 402; http://dx.doi.org/10.1111/j.1477-2574.2010.00185.x; PMID: 20662790
   PubMed Web of Science ®Google Scholar
• Phua LC, Koh PK, Cheah PY, Ho HK, Chan ECY. Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 937:103 - 13; http://dx.doi.org/10.1016/j.jchromb.2013.08.025; PMID: 24029555
   PubMed Web of Science ®Google Scholar
• Jiménez B, Mirnezami R, Kinross J, Cloarec O, Keun HC, Holmes E, Goldin RD, Ziprin P, Darzi A, Nicholson JK. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic “field-effects” enables colorectal cancer staging and prognostication. J Proteome Res 2013; 12:959 - 68; http://dx.doi.org/10.1021/pr3010106; PMID: 23240862
   PubMed Web of Science ®Google Scholar
• Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One 2013; 8:e70803; http://dx.doi.org/10.1371/journal.pone.0070803; PMID: 23940645
   PubMed Web of Science ®Google Scholar
• Godoy A, Ulloa V, Rodríguez F, Reinicke K, Yañez AJ, García MdeL, Medina RA, Carrasco M, Barberis S, Castro T, et al. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J Cell Physiol 2006; 207:614 - 27; http://dx.doi.org/10.1002/jcp.20606; PMID: 16523487
   PubMed Web of Science ®Google Scholar
• Zlobec I, Bihl MP, Schwarb H, Terracciano L, Lugli A. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis. Int J Cancer 2010; 127:367 - 80; PMID: 19908233
   PubMed Web of Science ®Google Scholar
• Kirkland JB. Niacin requirements for genomic stability. Mutat Res 2012; 733:14 - 20; http://dx.doi.org/10.1016/j.mrfmmm.2011.11.008; PMID: 22138132
   PubMed Web of Science ®Google Scholar
• Mayo B, van Sinderen D. Bifidobacteria: Genomics and Molecular Aspects. Caister Acad. Press, 2010.
   Google Scholar
• Vandendool H, Kratz PD. A Generalization of the Retention Index System Including Linear Temperature Programmed Gas-Liquid Partition Chromatography. J Chromatogr 1963; 11:463 - 71; http://dx.doi.org/10.1016/S0021-9673(01)80947-X; PMID: 14062605
   PubMed Web of Science ®Google Scholar
• Verner P. Separation, quantification and identification of non-volatile organic acids in body fluids by gas chromatography. J Pharm Biomed Anal 1988; 6:131 - 50; http://dx.doi.org/10.1016/0731-7085(88)80040-2; PMID: 16867427
   PubMed Web of Science ®Google Scholar
• van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 2006; 7:142; http://dx.doi.org/10.1186/1471-2164-7-142; PMID: 16762068
   PubMed Web of Science ®Google Scholar